Statins were also associated with prolonged survival in non-small cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)s [36]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.